These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 6823505)

  • 1. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV; Prentice RL; Ishimaru T; Kato H; Mason M
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of various aspects of atomic bomb dose estimation at RERF using data on acute radiation symptoms.
    Gilbert ES; Ohara JL
    Radiat Res; 1984 Oct; 100(1):124-38. PubMed ID: 6494426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of cigarette smoking and radiation exposure to cancer mortality in Hiroshima and Nagasaki.
    Prentice RL; Yoshimoto Y; Mason MW
    J Natl Cancer Inst; 1983 Apr; 70(4):611-22. PubMed ID: 6572749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86).
    Shimizu Y; Kato H; Schull WJ
    Radiat Res; 1990 Feb; 121(2):120-41. PubMed ID: 2305030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants.
    Matsuura M; Hayakawa N; Shimokata H
    Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiation risks. Results of the new evaluation].
    Kellerer AM
    Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced cancer and its modifying factor among A-bomb survivors.
    Kato H
    Princess Takamatsu Symp; 1987; 18():117-24. PubMed ID: 3506538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents.
    Prentice RL; Kato H; Yoshimoto K; Mason M
    Natl Cancer Inst Monogr; 1982; 62():207-12. PubMed ID: 7167191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic cell mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors: implications for radiation carcinogenesis.
    Kyoizumi S; Akiyama M; Cologne JB; Tanabe K; Nakamura N; Awa AA; Hirai Y; Kusunoki Y; Umeki S
    Radiat Res; 1996 Jul; 146(1):43-52. PubMed ID: 8677297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological study on lung cancer among A-bomb survivors in Hiroshima.
    Shimizu K
    Hiroshima J Med Sci; 1967 Dec; 16(3):241-53. PubMed ID: 5602854
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
    Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
    J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.